Questioning the justification for a fourth SARS-CoV-2 vaccine.
作者信息
Calderon-Margalit Ronit, Strahilevitz Jacob, Paltiel Ora
机构信息
Braun School of Public Health, Hadassah Medical Center, Faculty of Medicine, Hebrew University, Jerusalem, Israel.
Department of Clinical Microbiology and Infectious Diseases, Hadassah Hebrew University Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
出版信息
Clin Microbiol Infect. 2022 Jul;28(7):905-907. doi: 10.1016/j.cmi.2022.03.023. Epub 2022 Mar 23.
Abstract
摘要
相似文献
1
Questioning the justification for a fourth SARS-CoV-2 vaccine.质疑第四剂新冠病毒疫苗的合理性。
Clin Microbiol Infect. 2022 Jul;28(7):905-907. doi: 10.1016/j.cmi.2022.03.023. Epub 2022 Mar 23.
2
Immunophenotyping of SARS-CoV-2 and vaccine design.新型冠状病毒 2 型的免疫表型分析与疫苗设计
Vaccine. 2022 Jun 26;40(30):3985-3986. doi: 10.1016/j.vaccine.2022.04.071.
3
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
4
A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection.一种表达融合前稳定的 SARS-CoV-2 刺突蛋白的 MVA 疫苗单次接种即可中和关注变体，并保护小鼠免受致死性 SARS-CoV-2 感染。
Front Immunol. 2022 Jan 27;12:824728. doi: 10.3389/fimmu.2021.824728. eCollection 2021.
5
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.用于 COVID-19 的疫苗：从核酸疫苗到作为传递载体系统的卡介苗的观点。
Microbes Infect. 2020 Nov-Dec;22(10):515-524. doi: 10.1016/j.micinf.2020.09.004. Epub 2020 Sep 19.
6
Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8 T cell responses.非中和抗体依赖的 SARS-CoV-2 控制与鼻内疫苗诱导的 CD8 T 细胞反应相关。
Cell Rep Med. 2022 Jan 19;3(2):100520. doi: 10.1016/j.xcrm.2022.100520. eCollection 2022 Feb 15.
7
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.以色列卫生保健工作者中，第三剂 BNT162b2 疫苗接种与 SARS-CoV-2 感染发生率的关联。
JAMA. 2022 Jan 25;327(4):341-349. doi: 10.1001/jama.2021.23641.
8
A protective AAV vaccine for SARS-CoV-2.一种针对新型冠状病毒的腺相关病毒保护性疫苗。
Signal Transduct Target Ther. 2022 Sep 5;7(1):310. doi: 10.1038/s41392-022-01158-w.
9
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.辉瑞-BioNTech 新冠疫苗接种 6 个月后针对 SARS-CoV-2 关注变异株的抗体反应
Microbiol Spectr. 2022 Apr 27;10(2):e0225221. doi: 10.1128/spectrum.02252-21. Epub 2022 Mar 9.
10
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.在接受 mRNA-1273 疫苗接种者的血浆中检测到循环严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）疫苗抗原。
Clin Infect Dis. 2022 Mar 1;74(4):715-718. doi: 10.1093/cid/ciab465.
引用本文的文献
1
Caveats of chimpanzee ChAdOx1 adenovirus-vectored vaccines to boost anti-SARS-CoV-2 protective immunity in mice.用于增强小鼠抗SARS-CoV-2保护性免疫的黑猩猩ChAdOx1腺病毒载体疫苗的注意事项。
Appl Microbiol Biotechnol. 2024 Jan 27;108(1):179. doi: 10.1007/s00253-023-12927-0.
2
Three-year COVID-19 and flu vaccinations among medical residents in a tertiary hospital in Italy: The threat of acceptance decline in seasonal campaigns.意大利一家三级医院的住院医师接种三年 COVID-19 和流感疫苗：季节性疫苗接种活动中接受度下降的威胁。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2252708. doi: 10.1080/21645515.2023.2252708.
3
Attitudes of Healthcare Workers in Israel towards the Fourth Dose of COVID-19 Vaccine.以色列医护人员对新冠疫苗第四剂的态度
Vaccines (Basel). 2023 Feb 7;11(2):385. doi: 10.3390/vaccines11020385.
本文引用的文献
1
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.在以色列，第四剂 BNT162b2 对奥密克戎的保护作用。
N Engl J Med. 2022 May 5;386(18):1712-1720. doi: 10.1056/NEJMoa2201570. Epub 2022 Apr 5.
2
Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients.新冠疫苗接种者中不同的 SARS-CoV-2 奥密克戎反应性 T 和 B 细胞应答。
Sci Immunol. 2022 Mar 25;7(69):eabo2202. doi: 10.1126/sciimmunol.abo2202.
3
A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.《COVID-19医疗应对国家战略：疫苗与治疗方法》
JAMA. 2022 Jan 18;327(3):215-216. doi: 10.1001/jama.2021.24165.
4
Protection against Covid-19 by BNT162b2 Booster across Age Groups.辉瑞-BioNTech 疫苗加强针在各年龄段对预防新冠病毒的保护作用
N Engl J Med. 2021 Dec 23;385(26):2421-2430. doi: 10.1056/NEJMoa2115926. Epub 2021 Dec 8.
5
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
Zotero 插件